A
Abingworth Portfolio holdings
AUM
$307M
This Quarter Return
+23.51%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
–
AUM
$207M
AUM Growth
+$207M
(+31%)
Cap. Flow
+$42.3M
Cap. Flow
% of AUM
20.43%
Top 10 Holdings %
Top 10 Hldgs %
98.36%
Holding
16
New
2
Increased
3
Reduced
1
Closed
–
Top Buys
| 1 |
Phathom Pharmaceuticals
PHAT
|
$37.4M |
| 2 |
Soleno Therapeutics
SLNO
|
$6.58M |
| 3 |
MTEM
Molecular Templates, Inc.
MTEM
|
$2.8M |
| 4 |
Exicure
XCUR
|
$2.07M |
| 5 |
Protara Therapeutics
TARA
|
$51.9K |
Top Sells
| 1 |
CRISPR Therapeutics
CRSP
|
$6.65M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Personalis
PSNL
$434M
| $59.3M | 28.65% | 5,449,294 | – | – |
|
|
2
Phathom Pharmaceuticals
PHAT
$864M
| $37.4M | 18.09% | +1,203,135 | New | +$37.4M |
|
|
3
CRISPR Therapeutics
CRSP
$4.71B
| $31.6M | 15.28% | 519,198 -109,200 | -17% | -$6.65M |
|
|
SIEN
4
DELISTED
Sientra, Inc.
SIEN
| $21.3M | 10.31% | 2,390,843 | – | – |
|
|
5
Soleno Therapeutics
SLNO
$3.6B
| $19.9M | 9.63% | 6,969,272 +2,300,000 | +49% | +$6.58M |
|
|
6
Exicure
XCUR
$35.4M
| $19.9M | 9.61% | 6,977,000 +727,000 | +12% | +$2.07M |
|
|
VRNA
7
Verona Pharma
VRNA
$9.16B
| $5.23M | 2.53% | 901,943 | – | – |
|
|
PRTK
8
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $4.19M | 2.02% | 1,041,131 | – | – |
|
|
MTEM
9
DELISTED
Molecular Templates, Inc.
MTEM
| $2.8M | 1.35% | +200,000 | New | +$2.8M |
|
10
Spyre Therapeutics
SYRE
$996M
| $1.84M | 0.89% | 240,500 | – | – |
|
|
CHMA
11
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $1.84M | 0.89% | 370,671 | – | – |
|
|
12
Protara Therapeutics
TARA
$120M
| $879K | 0.42% | 2,144,517 +126,645 | +6% | +$51.9K |
|
|
OBSV
13
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $335K | 0.16% | 87,999 | – | – |
|
|
CBAY
14
DELISTED
Cymabay Therapeutics
CBAY
| $256K | 0.12% | 131,036 | – | – |
|
|
SRRA
15
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $74K | 0.04% | 216,667 | – | – |
|
16
Ocugen
OCGN
$319M
| $4K | ﹤0.01% | 7,111 | – | – |
|